Table 5.
Clinical characteristics, bioelectrical impedance, physical performance, physical function, and bio-humoral measures according to obesity and sarcopenic obesity.
| Obese (N = 17) | Sarcopenic Obesity (N = 7) | p | |
|---|---|---|---|
| Age (years) | 77.6 ± 1.7 | 85.0 ± 3.0 | 0.05 |
| BMI (kg/m2) | 34.8 ± 1.5 | 33.2 ± 0.8 | 0.5 |
| BIA measurements | |||
| BMR (Kcal) | 1396.5 ± 53.0 | 1144.3 ± 41.1 | 0.008 |
| PhA | 4.8 ± 0.4 | 3.6 ± 0.2 | 0.1 |
| TBW (L) | 42.9 ± 1.9 | 32.9 ± 1.3 | 0.001 |
| LM (kg) | 55.8 ± 3.0 | 44.9 ± 1.8 | 0.007 |
| BCM (kg) | 24.7 ± 1.7 | 16.7 ± 1.3 | 0.01 |
| BFM (%) | 33.8 ± 2.4 | 45.0 ± 1.9 | 0.004 |
| BFM (kg) | 29.6 ± 2.5 | 36.8 ± 1.9 | 0.05 |
| ASM | 21.0 ± 1.1 | 15.4 ± 0.8 | 0.004 |
| ASM/BMI | 0.6 ± 0.02 | 0.5 ± 0.02 | 0.003 |
| Physical measures | |||
| SPPB | 3.7 ± 0.9 | 0.0 ± 0.0 | 0.01 |
| ADL | 1.9 ± 0.5 | 4.0 ± 0.7 | 0.08 |
| IADL | 2.8 ± 0.7 | 5.7 ± 0.7 | 0.02 |
| Bio-Humoral measures | |||
| CRP (mg/L) | 17.11 ± 3.8 | 62.3 ± 22.1 | 0.005 |
| IL-6 (pg/mL) | 26.0 ± 7.1 | 41.7 ± 16.0 | 0.04 |
| Glycemia (mg/dL) | 110 ± 6.4 | 87.9 ± 4.0 | 0.02 |
| Creatinine (mg/dL) | 1.07 ± 0.1 | 1.02 ± 0.1 | 0.6 |
| Cystatin C (mg/mL) | 1.7 ± 0.3 | 1.6 ± 0.1 | 0.5 |
| Calculated indexes | |||
| CCR index | 0.68 ± 0.1 | 0.62 ± 0.1 | 0.5 |
| SI index | 42.9 ± 4.0 | 35.8 ± 3.2 | 0.3 |
Data were expressed as mean ± standard error. The difference between groups was tested by the Kruskal–Wallis-Multiple comparison Z-value test (Dunn’s test). Abbreviations: ADL: activities of daily living; ASM, appendicular skeletal mass; BCM, body cell mass; BFM, body fat mass; BMI, body mass index; BMR, basal metabolic rate; CCR, creatinine/cystatin C ratio; CRP, C-reactive protein; IADL, Instrumental Activities of Daily Living; LM, lean mas; N, number of subjects; PhA, phase angle; SI, sarcopenia index; SPPB, Short Performance Physical Battery.